Neuroimaging Mechanisms by Which Memory and Glucocorticoids Promote Risky Drinking
1 other identifier
interventional
27
1 country
1
Brief Summary
The purpose of this study is to determine whether hydrocortisone biases formation of alcohol-related memories to potentiate drinking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for early_phase_1
Started May 2021
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 12, 2021
CompletedFirst Submitted
Initial submission to the registry
May 17, 2021
CompletedFirst Posted
Study publicly available on registry
May 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2022
CompletedJune 2, 2022
June 1, 2022
10 months
May 17, 2021
June 1, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
Changes fMRI signal
Changes in fMRI signal at encoding will be assessed over an hour long period.
1 hour
Item memory
Item memory will be assessed through performance on delayed memory assessments. Item memory is determined by the accuracy of memory for individual items and will be expressed as dprime.
Up to 90 minutes
Context memory
Context memory will be assessed through performance on delayed memory assessments. Context memory is determined by the accuracy of memory for associated contexts and will be expressed as % correct.
Up to 90 minutes
Affect memory
Affect memory will be assessed through performance on delayed memory assessments. Affect memory is determined by subjective ratings of vividness (1-4), change in ratings from encoding to retrieval of memory (0-3). The score is averaged where a higher score indicates greater affect.
Up to 90 minutes
Secondary Outcomes (4)
Alcohol motivation
10 minutes
Affect - Negative
10 minutes
Affect - Positive
10 minutes
Neuroendocrine/cortisol reactivity
Baseline to 2 hours
Study Arms (2)
hydrocortisone
EXPERIMENTALParticipants receive hydrocortisone (20mg)
placebo
PLACEBO COMPARATORParticipants receive placebo.
Interventions
Eligibility Criteria
You may qualify if:
- Able to read and write English
- BMI 18-35
- Beer drinking
You may not qualify if:
- Meet current criteria for any substance use disorder, excluding caffeine
- Current significant medical conditions or psychiatric symptoms requiring medication
- Current use of medications/drugs that interfere with the HPA axis response
- Peri and post-menopausal women, pregnant or lactating women, and those with hysterectomies
- Metal in body (for MRI safety)
- Systemic fungal infections (contraindication for hydrocortisone)
- Known hypersensitivity to components of hydrocortisone tablets (hydrocortisone, calcium stearate, corn starch, lactose, mineral oil, sorbic acid, sucrose)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
Study Sites (1)
Yale University
New Haven, Connecticut, 06511, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth V Goldfarb, PhD
Yale University
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 17, 2021
First Posted
May 21, 2021
Study Start
May 12, 2021
Primary Completion
March 15, 2022
Study Completion
March 15, 2022
Last Updated
June 2, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Immediately following publication with no end date.
- Access Criteria
- Anyone who wishes to have access to the data may do so.
Individual participant data that underlie the results reported in published articles will be shared after de-identification.